Additional Details

  • AlloSure Lung Assessment and Metagenomics Outcomes Study

    University of CO Anschutz Medical Campus
    Aurora CO. 80045
    View Details

  • AlloSure Lung Assessment and Metagenomics Outcomes Study

    AdventHealth Orlando
    Orlando FL. 32804
    View Details

  • AlloSure Lung Assessment and Metagenomics Outcomes Study

    UT Health/ Memorial Hermann Hospital
    Houston TX. 77030
    View Details

  • AlloSure Lung Assessment and Metagenomics Outcomes Study

    St. Joseph's Hospital & Medical Center
    Phoenix AZ. 85013
    View Details

  • AlloSure Lung Assessment and Metagenomics Outcomes Study

    University of California (UCSF) School of Medicine
    San Francisco CA. 94143
    View Details

  • AlloSure Lung Assessment and Metagenomics Outcomes Study

    Vanderbilt University Medical Center
    Nashville TN. 37232
    View Details

  • AlloSure Lung Assessment and Metagenomics Outcomes Study

    University of Alabama (UAB)
    Birmingham AL. 35233
    View Details

  • AlloSure Lung Assessment and Metagenomics Outcomes Study

    Brigham and Womens Hospital
    Boston MA. 02115
    View Details

  • AlloSure Lung Assessment and Metagenomics Outcomes Study

    Inova
    Falls Church VA. 22042
    View Details

  • AlloSure Lung Assessment and Metagenomics Outcomes Study

    University of Pennsylvania
    Philadelphia PA. 19104
    View Details

  • AlloSure Lung Assessment and Metagenomics Outcomes Study

    Loyola University Medical School
    Maywood IL. 60153
    View Details

  • A Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants With Idiopathic Pulmonary Fibrosis

    Temple University
    Philadelphia PA. 19140
    View Details

  • A Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants With Idiopathic Pulmonary Fibrosis

    Local Institution - 0197
    Columbus OH. 43201
    View Details

  • A Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants With Idiopathic Pulmonary Fibrosis

    Local Institution - 0204
    Kansas City KS. 66160
    View Details

  • A Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants With Idiopathic Pulmonary Fibrosis

    Local Institution - 0174
    St Louis MO. 63110-1010
    View Details

  • A Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants With Idiopathic Pulmonary Fibrosis

    Local Institution - 0362
    Seattle WA. 98195
    View Details

  • A Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants With Idiopathic Pulmonary Fibrosis

    Local Institution - 0373
    Tulsa OK. 74133
    View Details

  • A Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants With Idiopathic Pulmonary Fibrosis

    Local Institution - 0417
    Toledo OH. 43608-2603
    View Details

  • A Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants With Idiopathic Pulmonary Fibrosis

    Local Institution - 0097
    Houston TX. 77030
    View Details

  • A Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants With Idiopathic Pulmonary Fibrosis

    Local Institution - 0188
    Charleston SC. 29425
    View Details